evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/geneAliases/8,gene/geneAliases/9,gene/geneAliases/10,gene/geneAliases/11,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract
10810,GENE_BACKGROUND,,"The TGBR1 gene encodes transforming growth factor receptor ß (TGFß) receptor 1, a type-I member of the family of TGFß receptors. TGBR1 is a serine/threonine protein kinase that heterodimerizes with other receptor-family members upon binding of a ligand belonging to the TGFß family. Following ligand activation, TGFBR1 phosphorylates its dimerization partner and induces phosphorylation of downstream effectors such as the SMAD proteins which control gene regulation (PMID: 22992590, 18662538). TGFß signaling controls multiple biological processes including cellular proliferation, differentiation and tissue homeostasis and, as such, is implicated in multiple human disorders (PMID: 22992590, 11057902). TGF-ß can function both as a tumor suppressor and tumor promoter (PMID: 11057902, 20001556). Inactivating mutations in TGBR1 have been detected in ovarian and breast cancer while deletions have been observed in pancreatic and biliary cancers as well as lymphomas (PMID: 22992590, 11057902). Single nucleotide polymorphisms in TGFBR1 can cause the autosomal Loeys-Dietz syndrome type 1 and have also been found in individuals with Marfan and similar syndromes (PMID: 16928994,16791849, 16596670, 18781618). Mutations associated with Loeys-Dietz syndrome were shown in cell lines to inactive the receptor function and to predispose carriers to allergic disorders (PMID: 22414221, 23884466). Other hereditary variants have been found to be associated with non-small cell lung cancer (PMID: 21225232, 19690145). Targeting of the TGFß pathway is being explored as a therapeutic approach in multiple cancers, focusing on either the production of ligand, its receptors or the downstream mediators; these therapies are based on the idea that TGFß exerts an immunosuppressive effect in certain tumors (PMID: 11057902, 18662538). Small molecules inhibiting TGFBR1's kinase function have entered into clinical trials (PMID: 11057902, 18662538).",,2017-04-07,,7046,TGFBR1,transforming growth factor beta receptor 1,False,ENST00000374994,NM_004612.2,TGFR-1,LDS1A,LDS2A,LDS1,ALK5,ACVRLK4,ESS1,MSSE,SKR4,tbetaR-I,AAT5,ALK-5,True,16596670,"FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited.",American journal of medical genetics. Part A,2018-05-15T20:06:00,140,10,1047-58,Adès LC et al,,,0001-05-15,,20001556,Targeting the transforming growth factor-beta signaling pathway in human cancer.,Expert opinion on investigational drugs,2018-01-01T20:10:00,19,True,77-91,Nagaraj NS et al,doi: 10.1517/13543780903382609,,0001-01-01,,23884466,TGFβ receptor mutations impose a strong predisposition for human allergic disease.,Science translational medicine,2018-07-24T20:13:00,5,195,195ra94,Frischmeyer-Guerrerio PA et al,doi: 10.1126/scitranslmed.3006448,,0001-07-24,,18781618,"Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders.",Human mutation,2018-11-01T20:08:00,29,11,E284-95,Stheneur C et al,doi: 10.1002/humu.20871,,0001-11-01,,11057902,"TGFbeta signaling in growth control, cancer, and heritable disorders.",Cell,2018-10-13T20:00:00,103,2,295-309,Massagué J et al,,,2018-10-13T03:09:00,,16928994,Aneurysm syndromes caused by mutations in the TGF-beta receptor.,The New England journal of medicine,2018-08-24T20:06:00,355,8,788-98,Loeys BL et al,,,0001-08-24,,16791849,Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders.,Human mutation,2018-08-01T20:06:00,27,8,760-9,Mátyás G et al,,,0001-08-01,,22414221,TGFBR1 mutations associated with Loeys-Dietz syndrome are inactivating.,Journal of receptor and signal transduction research,2018-06-01T20:12:00,32,3,150-5,Cardoso S et al,doi: 10.3109/10799893.2012.664553,,0001-06-01,,21225232,A haplotype of TGFBR1 is predominantly found in non-small cell lung cancer patients displaying TGFBR1 allelic-specific expression.,Oncology reports,2018-03-01T20:11:00,25,3,685-91,0001-01-07,doi: 10.3892/or.2011.1135,,0001-03-01,,18662538,TGFbeta in Cancer.,Cell,2018-07-25T20:08:00,134,2,215-30,Massagué J,doi: 10.1016/j.cell.2008.07.001,,0001-07-25,,22992590,TGFβ signalling in context.,Nature reviews. Molecular cell biology,2018-10-01T20:12:00,13,10,616-30,Massagué J,doi: 10.1038/nrm3434,,0001-10-01,,19690145,TGFBR1 haplotypes and risk of non-small-cell lung cancer.,Cancer research,2018-09-01T20:09:00,69,17,7046-52,Lei Z et al,doi: 10.1158/0008-5472.CAN-08-4602,,0001-09-01,
10809,GENE_SUMMARY,,"TGFBR1 encodes a receptor kinase that signals to downstream effectors in the TGFß signaling pathway. TGFBR1 is infrequently mutated in cancer; however, germline mutations in this gene are associated with Marfans syndrome and Loeys-Dietz syndrome.",,2017-04-07,,7046,TGFBR1,transforming growth factor beta receptor 1,False,ENST00000374994,NM_004612.2,TGFR-1,LDS1A,LDS2A,LDS1,ALK5,ACVRLK4,ESS1,MSSE,SKR4,tbetaR-I,AAT5,ALK-5,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
